Research & Literature

Cushing's syndrome: update on signs, symptoms and biochemical screening.

Nieman LK

European journal of endocrinology 2015; (173(4)):M33-8 doi:10.1530/EJE-15-0464.

Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Nieman LK, Biller BM, Findling JW, et al.

The Journal of clinical endocrinology and metabolism 2015; (100(8)):2807-31 doi:10.1210/jc.2015-1818.

Preparing Children for Court: Effects of a Model Court Education Program on Children's Anticipatory Anxiety.

Nathanson R, Saywitz KJ

Behavioral sciences & the law 2015; (33(4)):459-75 doi:10.1002/bsl.2191.

Outcome of Transsphenoidal Surgery for Cushing Disease: A Single-Center Experience Over 32 Years.

Chandler WF, Barkan AL, Hollon T, et al.

Neurosurgery 2016; (78(2)):216-23 doi:10.1227/NEU.0000000000001011.

The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing's disease.

Hayashi K, Inoshita N, Kawaguchi K, et al.

European journal of endocrinology 2016; (174(2)):213-26 doi:10.1530/EJE-15-0689.

Outcome of Microscopic Transsphenoidal Surgery in Cushing Disease: A Case Series of 96 Patients.

Shirvani M, Motiei-Langroudi R, Sadeghian H

World neurosurgery 2016; (87()):170-5.

[Cyclic Cushing's Syndrome - rare or rarely recognized].

Kiałka M, Doroszewska K, Mrozińska S, et al.

Przeglad lekarski 2015; (72(2)):74-7.

Diagnosis of cyclic Cushing syndrome using the morning urine free cortisol to creatinine ratio.

Jang YS, Lee IS, Lee JM, et al.

The Korean journal of internal medicine 2016; (31(1)):184-7 doi:10.3904/kjim.2016.31.1.184.

Bilateral inferior petrosal sinus sampling: experience in 327 patients.

Deipolyi A, Bailin A, Hirsch JA, et al.

Journal of neurointerventional surgery 2017; (9(2)):196-199 doi:10.1136/neurintsurg-2015-012164.

[Retrospective analysis to evaluate efficacy and safety of stereotactic radiosurgery in Cushing's disease: 24 cases and a review].

Roldán Serrano MA, Horcajadas Almansa A, Torres Vela E, et al.

Neurocirugia (Asturias, Spain) 2016; (27(4)):167-75.

Cushing's disease: pathobiology, diagnosis, and management.

Lonser RR, Nieman L, Oldfield EH

Journal of neurosurgery 2017; (126(2)):404-417 doi:10.3171/2016.1.JNS152119.

Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study.

Clayton RN, Jones PW, Reulen RC, et al.

The lancet. Diabetes & endocrinology 2016; (4(7)):569-76.

Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Prete A, Paragliola RM, Bottiglieri F, et al.

Endocrine 2017; (55(3)):969-980 doi:10.1007/s12020-016-1007-5.

From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal.

Asa SL, Casar-Borota O, Chanson P, et al.

Endocrine-related cancer 2017; (24(4)):C5-C8 doi:10.1530/ERC-17-0004.

Surgical outcomes in patients with Cushing's disease: the Cleveland clinic experience.

Johnston PC, Kennedy L, Hamrahian AH, et al.

Pituitary 2017; (20(4)):430-440 doi:10.1007/s11102-017-0802-1.

Overexpression of T-box Transcription Factor 5 (TBX5) Inhibits Proliferation and Invasion in Non-Small Cell Lung Carcinoma Cells.

Ma R, Yang Y, Tu Q, Hu K

Oncology research 2017; (25(9)):1495-1504 doi:10.3727/096504017X14883287513729.

Normalized Early Postoperative Cortisol and ACTH Values Predict Nonremission After Surgery for Cushing Disease.

Asuzu D, Chatain GP, Hayes C, et al.

The Journal of clinical endocrinology and metabolism 2017; (102(7)):2179-2187 doi:10.1210/jc.2016-3908.

Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing's disease.

Ambrogio AG, Andrioli M, De Martin M, et al.

Endocrine connections 2017; (6(8)):791-799 doi:10.1530/EC-17-0292.

Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection.

Stolyarov Y, Mirocha J, Mamelak AN, Ben-Shlomo A

Pituitary 2018; (21(1)):41-49 doi:10.1007/s11102-017-0845-3.

Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.

Mayberg M, Reintjes S, Patel A, et al.

Journal of neurosurgery 2018; (129(5)):1268-1277.

Quality of Life in Cushing's disease: A long term issue?

Webb SM, Santos A, Resmini E, et al.

Annales d'endocrinologie 2018; (79(3)):132-137 doi:10.1016/j.ando.2018.03.007.

Prognostic Factors of Long-Term Remission After Surgical Treatment of Cushing's Disease.

Ioachimescu AG

Endocrinology and metabolism clinics of North America 2018; (47(2)):335-347 doi:10.1016/j.ecl.2018.02.002.

Characterization of cyclic Cushing's disease using late night salivary cortisol testing.

Jahandideh D, Swearingen B, Nachtigall LB, et al.

Clinical endocrinology 2018; (89(3)):336-345 doi:10.1111/cen.13758.

PATHOGENESIS OF CUSHING DISEASE: AN UPDATE ON THE GENETICS OF CORTICOTROPINOMAS.

Albani A, Perez-Rivas LG, Reincke M, Theodoropoulou M

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018; (24(10)):907-914 doi:10.4158/EP-2018-0111.

Mini-review of hair cortisol concentration for evaluation of Cushing syndrome.

Hodes A, Meyer J, Lodish MB, et al.

Expert review of endocrinology & metabolism 2018; (13(5)):225-231 doi:10.1080/17446651.2018.1517043.

Effects of Cognitive Behavioral Therapy on Neural Processing of Agoraphobia-Specific Stimuli in Panic Disorder and Agoraphobia.

Wittmann A, Schlagenhauf F, Guhn A, et al.

Psychotherapy and psychosomatics 2018; (87(6)):350-365 doi:10.1159/000493146.

Invasive ACTH-secreting pituitary macroadenoma in remission after transsphenoidal resection: A case report and literature review.

Zhuang Z, Liu X, Bao X, et al.

Medicine 2018; (97(46)):e13148 doi:10.1097/MD.0000000000013148.

The incidence of Cushing's disease: a nationwide Swedish study.

Ragnarsson O, Olsson DS, Chantzichristos D, et al.

Pituitary 2019; (22(2)):179-186 doi:10.1007/s11102-019-00951-1.

Successful reduction of ACTH secretion in a case of intractable Cushing's disease with pituitary Crooke's cell adenoma by combined modality therapy including temozolomide.

Tanaka S, Yamamoto M, Morita M, et al.

Endocrine journal 2019; (66(8)):701-708 doi:10.1507/endocrj.EJ18-0547.

Late-Night Salivary Cortisol: Cut-Off Definition and Diagnostic Accuracy for Cushing's Syndrome in a Portuguese Population.

Lages AS, Frade JG, Oliveira D, et al.

Acta medica portuguesa 2019; (32(5)):381-387 doi:10.20344/amp.11265.

Improvement in cognitive impairment following the successful treatment of endogenous Cushing's syndrome-a case report and literature review.

Brzozowska MM, Kepreotis S, Tsang F, Fuentes-Patarroyo SX

BMC endocrine disorders 2019; (19(1)):68 doi:10.1186/s12902-019-0401-4.

A commentary on Diagnosing Cushing's disease in the context of renal failure.

Raff H, Cohen EP, Findling JW

European journal of endocrinology 2019; (181(4)):C9-C11.

Cabergoline may act as a radioprotective agent in Cushing's disease.

Thakkar K, Lila A, Sarathi V, et al.

Clinical endocrinology 2020; (92(1)):55-62 doi:10.1111/cen.14123.

Quality of Life in Patients With Cushing's Disease.

Santos A, Resmini E, Martínez Momblán MA, et al.

Frontiers in endocrinology 2019; (10()):862 doi:10.3389/fendo.2019.00862.

Cushing's syndrome: Treatment and new therapeutic approaches.

Ferriere A, Tabarin A

Best practice & research. Clinical endocrinology & metabolism 2020; (34(2)):101381 doi:10.1016/j.beem.2020.101381.

Cushing syndrome: Old and new genes.

Tatsi C, Flippo C, Stratakis CA

Best practice & research. Clinical endocrinology & metabolism 2020; (34(2)):101418 doi:10.1016/j.beem.2020.101418.

The optimal numerosity of the referral population of pituitary tumors centers of excellence (PTCOE): A surgical perspective.

Mortini P, Nocera G, Roncelli F, et al.

Reviews in endocrine & metabolic disorders 2020; (21(4)):527-536 doi:10.1007/s11154-020-09564-7.

Liver metastases from pituitary carcinomas mimicking visceral well-differentiated neuroendocrine tumors: a series of four cases.

Venable ER, Kerr SE, Lopes MBS, et al.

Diagnostic pathology 2020; (15(1)):81 doi:10.1186/s13000-020-00997-x.

Outcomes of pituitary surgery for Cushing's disease: a systematic review and meta-analysis.

Stroud A, Dhaliwal P, Alvarado R, et al.

Pituitary 2020; (23(5)):595-609 doi:10.1007/s11102-020-01066-8.

Nelson's Syndrome: An Update.

Fountas A, Karavitaki N

Endocrinology and metabolism clinics of North America 2020; (49(3)):413-432 doi:10.1016/j.ecl.2020.05.004.

Pituitary Tumors Centers of Excellence.

Frara S, Rodriguez-Carnero G, Formenti AM, et al.

Endocrinology and metabolism clinics of North America 2020; (49(3)):553-564 doi:10.1016/j.ecl.2020.05.010.

Cortical thickness abnormalities in long-term remitted Cushing's disease.

Bauduin SEEC, van der Pal Z, Pereira AM, et al.

Translational psychiatry 2020; (10(1)):293 doi:10.1038/s41398-020-00980-6.

Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome.

Na S, Fernandes MA, Ioachimescu AG, Penna S

Behavioural neurology 2020; (2020()):4064370 doi:10.1155/2020/4064370.

Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome.

Kannankeril J, Carroll T, Findling JW, et al.

Journal of the Endocrine Society 2020; (4(10)):bvaa107 doi:10.1210/jendso/bvaa107.

Postoperative Day 1 Morning Cortisol Value as a Biomarker to Predict Long-term Remission of Cushing Disease.

Wang F, Catalino MP, Bi WL, et al.

The Journal of clinical endocrinology and metabolism 2021; (106(1)):e94-e102 doi:10.1210/clinem/dgaa773.

Suprasellar Tension Pneumatocele after Endoscopic Transsphenoidal Surgery for Pituitary Macroadenoma.

Sharma AK, Mehta R, Chandrakar N, et al.

Asian journal of neurosurgery 2020; (15(3)):763-765 doi:10.4103/ajns.AJNS_253_19.

USP8 and TP53 Drivers are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors.

Uzilov AV, Taik P, Cheesman KC, et al.

The Journal of clinical endocrinology and metabolism 2021; (106(3)):826-842 doi:10.1210/clinem/dgaa853.

Rapid response of Nelson's syndrome to pasireotide in radiotherapy-naive patient.

He X, Spencer-Segal JL

Clinical diabetes and endocrinology 2020; (6(1)):22 doi:10.1186/s40842-020-00110-7.

Medical therapy in severe hypercortisolism.

Marques JVO, Boguszewski CL

Best practice & research. Clinical endocrinology & metabolism 2021; (35(2)):101487 doi:10.1016/j.beem.2021.101487.

Outcomes of endoscopic transsphenoidal surgery for Cushing's disease.

Brady Z, Garrahy A, Carthy C, et al.

BMC endocrine disorders 2021; (21(1)):36 doi:10.1186/s12902-021-00679-9.

Approach to the Patient Treated with Steroidogenesis Inhibitors.

Castinetti F, Nieman LK, Reincke M, Newell-Price J

The Journal of clinical endocrinology and metabolism 2021; (106(7)):2114-2123 doi:10.1210/clinem/dgab122.

Preoperative prediction of granulation pattern subtypes in GH-secreting pituitary adenomas.

Heng L, Liu X, Jia D, et al.

Clinical endocrinology 2021; (95(1)):134-142 doi:10.1111/cen.14465.

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease.

Akirov A, Larouche V, Shimon I, et al.

Frontiers in endocrinology 2021; (12()):620005 doi:10.3389/fendo.2021.620005.

Inferior petrosal sinus sampling in Cushing's syndrome: usefulness and pitfalls.

Vassiliadi DA, Mourelatos P, Kratimenos T, Tsagarakis S

Endocrine 2021; (73(3)):530-539 doi:10.1007/s12020-021-02764-4.

Two-day low-dose dexamethasone suppression test more accurate than overnight 1-mg in women taking oral contraceptives.

Carton T, Mathieu E, Wolff F, et al.

Endocrinology, diabetes & metabolism 2021; (4(3)):e00255 doi:10.1002/edm2.255.

Adrenocorticotropic hormone (ACTH) independent Cushing's syndrome due to unilateral adrenocortical hyperplasia: two case reports.

Aouinati Y, Mjabber A, Haraj NE, et al.

The Pan African medical journal 2021; (38()):367 doi:10.11604/pamj.2021.38.367.26040.

Cushing Syndrome is Associated with Increased Stage N2 Sleep and Decreased SWS Partially Reversible After Treatment.

Ismailogullari S, Karaca Z, Firat ST, et al.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2021; (53(9)):608-615 doi:10.1055/a-1542-8816.

Morning Serum Cortisol as a Predictor for the HPA Axis Recovery in Cushing's Disease.

Cui Q, Liu D, Xiang B, et al.

International journal of endocrinology 2021; (2021()):4586229 doi:10.1155/2021/4586229.

USP8, USP48, and BRAF mutations differ in their genotype-phenotype correlation in Asian Indian patients with Cushing's disease.

Abraham AP, Pai R, Beno DL, et al.

Endocrine 2022; (75(2)):549-559 doi:10.1007/s12020-021-02903-x.

Cushing's disease.

Ferriere A, Tabarin A

Presse medicale (Paris, France : 1983) 2021; (50(4)):104091 doi:10.1016/j.lpm.2021.104091.

Cushing Disease: Medical and Surgical Considerations.

Bray DP, Rindler RS, Dawoud RA, et al.

Otolaryngologic clinics of North America 2022; (55(2)):315-329 doi:10.1016/j.otc.2021.12.006.

Overview of the 2022 WHO Classification of Pituitary Tumors.

Asa SL, Mete O, Perry A, Osamura RY

Endocrine pathology 2022; (33(1)):6-26 doi:10.1007/s12022-022-09703-7.

The Socioeconomic Consequences of Cushing's Syndrome: A Nationwide Cohort Study.

Ebbehoj A, Søndergaard E, Jepsen P, et al.

The Journal of clinical endocrinology and metabolism 2022; (107(7)):e2921-e2929 doi:10.1210/clinem/dgac174.

Long-term morbidity and mortality in patients with Cushing's syndrome.

Braun LT, Vogel F, Reincke M

Journal of neuroendocrinology 2022; (34(8)):e13113 doi:10.1111/jne.13113.

Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome).

Raff H

Pituitary 2022; (25(5)):698-700 doi:10.1007/s11102-022-01214-2.

Glucocorticoid Withdrawal Syndrome following treatment of endogenous Cushing Syndrome.

He X, Findling JW, Auchus RJ

Pituitary 2022; (25(3)):393-403 doi:10.1007/s11102-022-01218-y.

Endocrinopathies.

Sheely D, Pujare D

The Medical clinics of North America 2022; (106(3)):495-507 doi:10.1016/j.mcna.2021.12.010.

The diagnosis and management of Cushing's syndrome in pregnancy.

Hamblin R, Coulden A, Fountas A, Karavitaki N

Journal of neuroendocrinology 2022; (34(8)):e13118 doi:10.1111/jne.13118.

Altered hippocampal volume and functional connectivity in patients with Cushing's disease.

Li C, Zhang Y, Wang W, et al.

Brain and behavior 2022; (12(6)):e2507 doi:10.1002/brb3.2507.

Hypothalamic-pituitary-adrenal axis recovery after treatment of Cushing's syndrome.

Balasko A, Zibar Tomsic K, Kastelan D, Dusek T

Journal of neuroendocrinology 2022; (34(8)):e13172 doi:10.1111/jne.13172.

Pituitary surgery in Cushing's disease: first line treatment and role of reoperation.

Jones PS, Swearingen B

Pituitary 2022; (25(5)):713-717 doi:10.1007/s11102-022-01254-8.

Unmet needs in Cushing's syndrome: the patients' perspective.

Valassi E, Chiodini I, Feelders RA, et al.

Endocrine connections 2022; (11(7)).

Long-term follow-up and predictors of recurrence of Cushing's disease.

Guignat L, Bertherat J

Journal of neuroendocrinology 2022; (34(8)):e13186 doi:10.1111/jne.13186.

Clinical presentation and etiology of Cushing's syndrome: Data from ERCUSYN.

Valassi E

Journal of neuroendocrinology 2022; (34(8)):e13114 doi:10.1111/jne.13114.

Patient on Multiple Hormone Replacement Therapy for Hip Arthroplasty: How to Omit Noise and Be Focused?

Patel G, Kahlon S, Ganesh V

Cureus 2022; (14(8)):e27904 doi:10.7759/cureus.27904.

Anticipatory Anxiety, Familiarization, and Performance: Finding the Sweet Spot to Optimize High-Quality Data Collection and Minimize Subject Burden.

Streetman AE, Lewis AK, Rogers EL, et al.

European journal of investigation in health, psychology and education 2022; (12(9)):1349-1357 doi:10.3390/ejihpe12090094.

Clinical profile and treatment outcomes of patients with ectopic ACTH syndrome compared to Cushing disease: a single-center experience.

Attri B, Goyal A, Kalaivani M, et al.

Endocrine 2023; (80(2)):408-418 doi:10.1007/s12020-022-03298-z.

The volume-outcome relationship for endoscopic transsphenoidal pituitary surgery for benign neoplasm: analysis of an administrative dataset for England.

Gray WK, Navaratnam AV, Rennie C, et al.

British journal of neurosurgery 2025; (39(1)):44-51 doi:10.1080/02688697.2023.2175783.

MRI for Cushing Disease: A Systematic Review.

Castle-Kirszbaum M, Amukotuwa S, Fuller P, et al.

AJNR. American journal of neuroradiology 2023; (44(3)):311-316 doi:10.3174/ajnr.A7789.

Glucocorticoid withdrawal syndrome: what to expect and how to manage.

Theiler-Schwetz V, Prete A

Current opinion in endocrinology, diabetes, and obesity 2023; (30(3)):167-174 doi:10.1097/MED.0000000000000804.

The recovery time of hypothalamic-pituitary-adrenal axis after curative surgery in Cushing's disease and its related factor.

Cui Q, Liu X, Sun Q, et al.

Endocrine 2023; (81(2)):349-356 doi:10.1007/s12020-023-03405-8.

Bilateral inferior petrosal sinus sampling in the diagnosis of ACTH-dependent Cushing's syndrome: experience in a tertiary hospital.

Moreno Parro I, Ortiz Sánchez D, García Moreno R, et al.

Advances in laboratory medicine 2022; (3(3)):282-294 doi:10.1515/almed-2022-0088.

An individualized approach to the management of Cushing disease.

Fleseriu M, Varlamov EV, Hinojosa-Amaya JM, et al.

Nature reviews. Endocrinology 2023; (19(10)):581-599 doi:10.1038/s41574-023-00868-7.

Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?

Lee CH

Brain tumor research and treatment 2023; (11(3)):173-176 doi:10.14791/btrt.2023.0015.

Enhancing Cushing's disease diagnosis: exploring the impact of desmopressin on ACTH gradient during BIPSS.

de Almeida TS, Rodrigues TDC, Costenaro F, et al.

Frontiers in endocrinology 2023; (14()):1224001 doi:10.3389/fendo.2023.1224001.

Pilot study to define criteria for Pituitary Tumors Centers of Excellence (PTCOE): results of an audit of leading international centers.

Giustina A, Uygur MM, Frara S, et al.

Pituitary 2023; (26(5)):583-596 doi:10.1007/s11102-023-01345-0.

Long-term efficacy and safety of osilodrostat in patients with Cushing's disease: results from the LINC 4 study extension.

Gadelha M, Snyder PJ, Witek P, et al.

Frontiers in endocrinology 2023; (14()):1236465 doi:10.3389/fendo.2023.1236465.

Anticipatory anxiety and participation in cancer screening. A systematic review.

Goodwin B, Anderson L, Collins K, et al.

Psycho-oncology 2023; (32(12)):1773-1786 doi:10.1002/pon.6238.

Cushing's Disease: Long-Term Effectiveness and Safety of Osilodrostat in a Polish Group of Patients with Persistent Hypercortisolemia in the Experience of a Single Center.

Dzialach L, Sobolewska J, Respondek W, et al.

Biomedicines 2023; (11(12)) doi:10.3390/biomedicines11123227.

Clinical and Pathological Features of Pit1/SF1 Multilineage Pituitary Neuroendocrine Tumor.

Wang X, Tang H, Bie Z, et al.

Neurosurgery 2024; doi:10.1227/neu.0000000000002846.

[Diagnostic value of bilateral inferior petrosal sinus sampling in various modifications and methods of radiation and radionuclide imaging in the diagnosis and differential diagnosis of ACTH-dependent endogenous hypercortisolism].

Belaya ZE, Golounina OO, Sitkin II, et al.

Problemy endokrinologii 2024; (69(6)):4-16 doi:10.14341/probl13299.

7T MRI for Cushing Disease: A Single-Institution Experience and Literature Review.

Mark IT, Welker K, Erickson D, et al.

AJNR. American journal of neuroradiology 2024; (45(7)):971-976 doi:10.3174/ajnr.A8209.

Delineating the Spectrum of Pituitary Adenoma Based on the WHO 2017 Classification.

Paramita P, Shilpa R, Nandeesh BN, et al.

Neurology India 2024; (72(1)):96-101 doi:10.4103/neuroindia.NI_913_20.

Relevance of mutations in protein deubiquitinases genes and TP53 in corticotroph pituitary tumors.

Pękul M, Szczepaniak M, Kober P, et al.

Frontiers in endocrinology 2024; (15()):1302667 doi:10.3389/fendo.2024.1302667.

[18F]FET PET/MRI: An Accurate Technique for Detection of Small Functional Pituitary Tumors.

Pruis IJ, Verburg FA, Balvers RK, et al.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2024; (65(5)):688-692 doi:10.2967/jnumed.123.266853.

Challenges in the postsurgical recovery of cushing syndrome: glucocorticoid withdrawal syndrome.

Zhang CD, Ioachimescu AG

Frontiers in endocrinology 2024; (15()):1353543 doi:10.3389/fendo.2024.1353543.

Improvement in clinical features of hypercortisolism during osilodrostat treatment: findings from the Phase III LINC 3 trial in Cushing's disease.

Pivonello R, Fleseriu M, Newell-Price J, et al.

Journal of endocrinological investigation 2024; (47(10)):2437-2448 doi:10.1007/s40618-024-02359-6.

A clinicopathological study of non-functioning pituitary neuroendocrine tumours using the World Health Organization 2022 classification.

Woo CS, Ho RS, Ho G, et al.

Frontiers in endocrinology 2024; (15()):1368944 doi:10.3389/fendo.2024.1368944.

Medical treatment of functional pituitary adenomas, trials and tribulations.

Capatina C, Hanzu FA, Hinojosa-Amaya JM, Fleseriu M

Journal of neuro-oncology 2024; (168(2)):197-213 doi:10.1007/s11060-024-04670-x.

Video-Based Performance Analysis in Pituitary Surgery-Part 1: Surgical Outcomes.

Khan DZ, Koh CH, Das A, et al.

World neurosurgery 2024; (190()):e787-e796 doi:10.1016/j.wneu.2024.07.218.

Stereotactic radiosurgery for recurrent/residual nonfunctioning pituitary adenoma: a single-arm systematic review and meta-analysis.

De Nigris Vasconcellos F, Vilela MAD, Garcia Torrico F, et al.

Acta neurochirurgica 2024; (166(1)):392 doi:10.1007/s00701-024-06296-4.

Improved Clinical Outcomes During Long-term Osilodrostat Treatment of Cushing Disease With Normalization of Late-night Salivary Cortisol and Urinary Free Cortisol.

Newell-Price J, Fleseriu M, Pivonello R, et al.

Journal of the Endocrine Society 2024; (9(1)):bvae201 doi:10.1210/jendso/bvae201.

Lateralization outcomes of bilateral inferior petrosal sinus sampling: desmopressin vs CRH.

Erkan B, Cil MS, Cingoz M, et al.

Hormones (Athens, Greece) 2025; (24(2)):551-559 doi:10.1007/s42000-024-00620-4.

The diagnostic value of prolactin adjustment in bilateral inferior petrosal sinus sampling for differentiating Cushing's disease from the ectopic ACTH syndrome: a systematic review and meta-analysis.

Valizadeh M, Ahmadi AR, Hussein DR, et al.

Pituitary 2024; (28(1)):11 doi:10.1007/s11102-024-01474-0.

Pituitary adenomas: biology, nomenclature and clinical classification.

Ho KKY, Melmed S

Reviews in endocrine & metabolic disorders 2025; (26(2)):137-146 doi:10.1007/s11154-025-09944-x.

High recovery rate of adrenal function after successful surgical treatment of Cushing's syndrome.

van de Ven AC, van Houten P, Grevers L, et al.

Endocrine connections 2025; (14(5)).

Osilodrostat Treatment of Cushing Syndrome in Real-World Clinical Practice: Findings From the ILLUSTRATE study.

Fleseriu M, Auchus RJ, Huang W, et al.

Journal of the Endocrine Society 2025; (9(5)):bvaf046 doi:10.1210/jendso/bvaf046.

A case series of bilateral inferior petrosal sinus sampling using desmopressin for evaluation of ACTH-dependent cushing's syndrome in pediatric patients: insights from Iran.

Valizadeh M, Rahmani F, Nikoohemmat M, et al.

Journal of diabetes and metabolic disorders 2025; (24(1)):125 doi:10.1007/s40200-025-01634-4.

Prediction of remission and recurrence of Cushing's disease following transsphenoidal surgery (TSS): a single center, 20-year, retrospective series.

Natan DB, Serebro M, Ram Z, et al.

Endocrine 2025; (90(1)):256-265 doi:10.1007/s12020-025-04304-w.

Transcription factor-based classification of pituitary adenomas / PitNETs: a comparative analysis and clinical implications across WHO 2004, 2017 and 2022 in 921 cases.

Nasi-Kordhishti I, Hladik M, Kandilaris K, et al.

Acta neuropathologica communications 2025; (13(1)):135 doi:10.1186/s40478-025-02050-8.

Stereotactic radiosurgery and fractionated radiation therapy in the management of pituitary tumors.

Mantziaris G, Trifiletti DM, Pikis S, Sheehan JP

Neuro-oncology advances 2025; (7(Suppl 1)):i58-i68 doi:10.1093/noajnl/vdae010.

Salient Observations from Clinical Profile and Long-Term Outcome of a Cohort of Patients with Ectopic Cushing's Syndrome.

Arjunan D, Jain N, Shah R, et al.

Indian journal of endocrinology and metabolism 2025; (29(4)):434-439 doi:10.4103/ijem.ijem_96_25.

Update in the Management of ACTH-Secreting Gastroenteropancreatic and Thoracic Neuroendocrine Neoplasms.

Tsoli M, Bel-Ange A, Atlan K, et al.

Current treatment options in oncology 2025; (26(11)):1010-1022 doi:10.1007/s11864-025-01354-0.

Cushing Disease Mimicking Ectopic Adrenocorticotropic Hormone-Secreting Disease.

Fisher DL, Fraenkel M, Baraf L

AACE endocrinology and diabetes 2025; (12(3)):174-177 doi:10.1016/j.aed.2025.06.001.

Osilodrostat dose impact on efficacy/safety in Cushing's disease: large, pooled analysis of LINC 2, 3, and 4.

Fleseriu M, Pivonello R, Lacroix A, et al.

European journal of endocrinology 2025; (193(5)):606-617 doi:10.1093/ejendo/lvaf207.

Pituitary Neuroendocrine Tumor or Pituitary Adenoma? Let's Ask the Epigenome!

Dottermusch M

Endocrine pathology 2025; (36(1)):35 doi:10.1007/s12022-025-09879-8.

A comparison of bilateral internal jugular vein sampling with bilateral inferior petrosal sinus sampling at Mayo Clinic for the subtype evaluation of corticotropin-dependent cushing syndrome.

O'Keeffe DT, Maraka S, Kotwal A, et al.

Pituitary 2025; (28(6)):118 doi:10.1007/s11102-025-01595-0.

Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain.

Araujo-Castro M, García-Centeno R, González L, et al.

Journal of clinical medicine 2025; (14(21)) doi:10.3390/jcm14217575.

Rapid Endocrine Remission After ZAP-X Gyroscopic Radiosurgery for Cushing's Disease: A Case Report.

Kahvecioglu A, Tekin S, Oguz SH, et al.

Cureus 2025; (17(11)):e96636 doi:10.7759/cureus.96636.

Ectopic Adrenocorticotropic Hormone (ACTH)-Dependent Cushing Syndrome Secondary to Olfactory Neuroblastoma: A Rare Entity.

Eisa N

AACE endocrinology and diabetes 2025; (12(4)):249-254 doi:10.1016/j.aed.2025.08.004.

Iatrogenic Cushing's Syndrome and the Hidden Ingredient of Artri King.

Ataallah B, Al Tameemi M

Cureus 2026; (18(1)):e100843 doi:10.7759/cureus.100843.

Early postoperative LDDST enhances remission prediction beyond morning cortisol in cushing's disease.

Nasi-Kordhishti I, Oberle L, Goloshchapova K, Honegger J

Pituitary 2026; (29(1)):40.

From hypercortisolism to remission: impact of Cushing's disease on eating patterns.

Korkmaz Yilmaz M, Sehit Burhan H, Burhan S, et al.

Frontiers in endocrinology 2026; (17()):1726118 doi:10.3389/fendo.2026.1726118.